Wells Fargo & Company Re Shape Lifesciences Inc. Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.32 - $15.6 $3 - $171	-11 Reduced 6.92%	148 $0
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.25 $28 - $62	50 Added 45.87%	159 $0
Q1 2022 May 16, 2022	SELL	$0.86 - $1.86 $14 - $31	-17 Reduced 13.49%	109 $0
Q4 2021 Feb 14, 2022	BUY	$1.64 - $3.13 $137 - $262	84 Added 200.0%	126 $0
Q3 2021 Nov 15, 2021	BUY	$2.67 - $5.09 $64 - $122	24 Added 133.33%	42 $0
Q2 2021 Aug 16, 2021	BUY	$2.02 - $7.64 $36 - $137	18 New	18 $0

Ticker RSLS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,559,400
Market Cap $130M
Description
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.